Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical StudiesDong M. Shin, Zhuo Georgia Chen, Susan Müller et al.|Clinical Cancer Research|2013Cited by 61
Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung CancerSuresh S. Ramalingam, Fadlo R. Khuri, Taofeek K. Owonikoko et al.|Journal of Thoracic Oncology|2013Cited by 39
Abstract LB-194: Window of opportunity preoperative interrogation of mTOR pathway in patients with resectable non-small cell lung cancer (NSCLC).Taofeek K. Owonikoko, Fadlo R. Khuri, Daniel Miller et al.|Cancer Research|2013Cited by 0